Analysis of relapse and progression after myeloablative allogeneic stem cell transplantation for multiple myeloma

被引：0
|
作者：
Bonifazi, F [1 ]
Bandini, G [1 ]
Giovannini, M [1 ]
Stanzani, M [1 ]
Palandri, F [1 ]
Giannini, B [1 ]
Arpinati, M [1 ]
Falcioni, S [1 ]
Tosi, P [1 ]
Zamagni, E [1 ]
Cangini, D [1 ]
Tacchetti, P [1 ]
Baccarani, M [1 ]
Cavo, M [1 ]
机构：
[1] Inst Haematol Seragnoli, Bologna, Italy
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation in multiple myeloma
    Gonzalez, A. J.
    Gonzalez, S.
    Gonzalez, A. P.
    Alonso, E.
    Palomo, P.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S261 - S261
  • [22] Relapse after allogeneic stem cell transplantation
    Barrett, A. John
    Battiwalla, Minoo
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (04) : 429 - 441
  • [23] Superior long term progression free survival of myeloablative allogeneic hematopoietic stem cell transplantation for multiple myeloma compared to autologous hematopoietic stem cell transplantation after identical conditioning regimen
    Khaled, Yaser
    Kato, Koji
    Levine, John E.
    Mellacheruvu, Smitha
    Jakubowiak, Andrzej
    Krijanovski, Oleg
    Peres, Edward
    Reddy, Pavan
    Knott, Kevin
    Yanik, Greg
    Ferrara, James
    Mineishi, Shin
    BLOOD, 2007, 110 (11) : 890A - 890A
  • [24] Allogeneic transplantation following relapse after autologous transplantation in multiple myeloma
    Hoepfner, S
    Breitkreutz, I
    Möhler, T
    Benner, A
    Goldschmidt, H
    Ho, A
    Görner, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S12 - S13
  • [25] Disseminated toxoplasmosis after allogeneic stem cell transplantation for multiple myeloma
    Busemann, C.
    Ribback, S.
    Zimmermann, K.
    Seiler, V
    Kiefer, T.
    Schmidt, C. A.
    Dombrowski, F.
    Doelken, G.
    Krueger, W.
    ONKOLOGIE, 2010, 33 : 168 - 169
  • [26] Bortezomib for relapse after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for multiple myeloma
    Michallet, M
    Duscatelle, S
    Rafii, H
    Troncy, J
    Thiebaut, A
    Thomas, X
    Tavernier, E
    Le, QH
    Raus, N
    Praire, A
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S389 - S389
  • [27] Salvage of multiple myeloma patients relapse after an autologous stem cell transplantation, in the era of thalidomide and reduced-intensity allogeneic stem cell transplantation
    Hardan, I
    Kneller, A
    Shimoni, A
    Berkowicz, M
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Davidowich, Y
    Shemtov, N
    Ben Bassat, I
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S157
  • [28] Long-term outcome of autologous and myeloablative allogeneic stem cell transplantation for Multiple Myeloma.
    Kuruvilla, J
    Nevill, TJ
    Nitta, J
    Le, A
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Shepherd, JD
    BLOOD, 2003, 102 (11) : 475A - 475A
  • [29] Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
    Kumar, Shaji
    Zhang, Mei-Jie
    Li, Peigang
    Dispenzieri, Angela
    Milone, Gustavo A.
    Lonial, Sagar
    Krishnan, Amrita
    Maiolino, Angelo
    Wirk, Baldeep
    Weiss, Brendan
    Freytes, Cesar O.
    Vogl, Dan T.
    Vesole, David H.
    Lazarus, Hillard M.
    Meehan, Kenneth R.
    Hamadani, Mehdi
    Lill, Michael
    Callander, Natalie S.
    Majhail, Navneet S.
    Wiernik, Peter H.
    Nath, Rajneesh
    Kamble, Rammurti T.
    Vij, Ravi
    Kyle, Robert A.
    Gale, Robert Peter
    Hari, Parameswaran N.
    BLOOD, 2011, 118 (07) : 1979 - 1988
  • [30] Patterns of relapse of multiple myeloma (MM) after autologous stem cell transplantation
    Rio, B
    Hunault, M
    Mignot, L
    Zittoun, R
    Baumelou, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 345 - 345
12345